The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Frieder Bauss

Department of Pharmacology

Roche Diagnostics GmbH

Pharma Research Penzberg

Nonnenwald 2

Germany

[email]@roche.com

Name/email consistency: high

[Claim this account]

Affiliations

Department of Pharmacology, Roche Diagnostics GmbH, Pharma Research Penzberg, Nonnenwald 2, Germany. 2007 - 2008
Roche Diagnostics, Pharma Research Penzberg, Penzberg, Germany. 2005
Roche Diagnostics GmbH, Pharma Research, Bone Metabolism, Sandhofer Strasse 116, Germany. 2001 - 2004
Pharma Research, Bone Metabolism, Roche Diagnostics GmbH, Mannheim, Germany. 2002

References

Preclinical and clinical efficacy of the bisphosphonate ibandronate in cancer treatment. Bauss, F., Bergström, B. Curr. Clin. Pharmacol (2008) [Pubmed]
Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat. Bauss, F., Pfister, T., Papapoulos, S. J. Bone Miner. Metab. (2008) [Pubmed]
Effects of ibandronate on bone quality: preclinical studies. Bauss, F., Dempster, D.W. Bone (2007) [Pubmed]
Ibandronate in metastatic bone disease: a review of preclinical data. Bauss, F., Body, J.J. Anticancer. Drugs (2005) [Pubmed]
Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing. Bauss, F., Russell, R.G. Osteoporos. Int (2004) [Pubmed]
New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate. Bauss, F., Schenk, R.K., Hört, S., Müller-Beckmann, B., Sponer, G. J. Pharmacol. Toxicol. Methods (2004) [Pubmed]
Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats. Bauss, F., Wagner, M., Hothorn, L.H. J. Rheumatol. (2002) [Pubmed]
Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. Bauss, F., Lalla, S., Endele, R., Hothorn, L.A. J. Rheumatol. (2002) [Pubmed]
The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration. Bauss, F., Lang, K., Dony, C., Kling, L. Growth Horm. IGF Res. (2001) [Pubmed]